Search bioRxiv⌕ Search

Biology subjects

Geiger, E.

Publications and source records attributed to Geiger, E..

2 recordsLinked to original sources

Multi-Factor Coral Disease Risk Forecasting for Early Warning and Management

Ecological forecasts are becoming increasingly valuable tools for conservation and management. However, there are few examples of near real-time forecasting systems that account for the wide range of ecological complexities. We developed a new coral disease ecological forecasting system that explores a suite of ecological relationships and their uncertainty and investigates how forecast skill changes with shorter lead times. The Multi-Factor Coral Disease Risk product introduced here uses a combination of ecological and marine environmental conditions to predict risk of white syndromes and growth anomalies across reefs in the central and western Pacific and along the east coast of Australia and is available through the U.S. National Oceanic and Atmospheric Administration Coral Reef Watch program. This product produces weekly forecasts for a moving window of six months at [~]5 km resolution based on quantile regression forests. The forecasts show superior skill at predicting disease risk on withheld survey data from 2012-2020 compared with predecessor forecast systems, with the biggest improvements shown for predicting disease risk at mid-to high-disease levels. Most of the prediction uncertainty arises from model uncertainty and therefore prediction accuracy and precision do not improve substantially with shorter lead times. This result arises because many predictor variables cannot be accurately forecasted, which is a common challenge across ecosystems. Weekly forecasts and scenarios can be explored through an online decision support tool and data explorer, co-developed with end-user groups to improve use and understanding of ecological forecasts. The models provide near real-time disease risk assessments and allow users to refine predictions and assess intervention scenarios. This work advances the field of ecological forecasting with real world complexities, and in doing so, better supports near term decision making for coral reef ecosystem managers and stakeholders. Secondarily, we identify clear needs and provide recommendations to further enhance our ability to forecast coral disease risk.

ecology↗

MicroRNA levels in bone and blood change during bisphosphonate and teriparatide therapy in an animal model of postmenopausal osteoporosis

MicroRNAs control the activity of a variety of genes that are pivotal to bone metabolism. Therefore, the clinical utility of miRNAs as biomarkers and drug targets for bone diseases certainly merits further investigation. This study describes the use of an animal model of postmenopausal osteoporosis to generate a comprehensive dataset on miRNA regulation in bone tissue and peripheral blood during bone loss and specifically anti-resorptive and osteo-anabolic treatment.\n\nForty-two Sprague-Dawley rats were randomized to SHAM surgery (n=10) or ovariectomy (OVX, n=32). Eight weeks after surgery, OVX animals were further randomized to anti-resorptive treatment with zoledronate (n=11), osteo-anabolic treatment with teriparatide (n=11), or vehicle treatment (n=10). After 12 weeks of treatment, bone and serum samples were used for microRNA analysis using next-generation sequencing (NGS), mRNA levels using RT-qPCR, and bone microarchitecture analysis using nanoCT.\n\nOvariectomy resulted in loss of trabecular bone, which was fully rescued using osteo-anabolic treatment, and partially rescued using anti-resorptive treatment. NGS revealed that both, anti-resorptive and anabolic treatment had a significant impact on miRNA levels in bone tissue and serum: out of 426 detected miRNAs, 46 miRNAs were regulated by teriparatide treatment an d 10 by zoledronate treatment (p-adj. < 0.1). Interestingly, teriparatide and zoledronate treatment were able to revert miRNA changes in tissue and serum of untreated OVX animals, such as the up-regulation of miR-203a-3p, a known osteo-inhibitory miRNA. We confirmed previously established mechanisms of miR-203a by analyzing its direct target Dlx5 in femoral head.\n\nOur data reveal a significant effect of ovariectomy-induced bone loss, as well as the two major types of anti-osteoporotic treatment on miRNA transcription in femoral head tissue. These changes are associated with altered activity of target genes relevant to bone formation, such as Dlx5. The observed effects of bone loss and treatment response on miRNA levels in bone are also reflected in the peripheral blood, suggesting the possibility of minimally-invasive monitoring of bone-derived miRNAs using liquid biopsies.\n\nHighlightsO_LImicroRNA expression in bone tissue is altered by osteo-anabolic and anti-resorptive therapy in OVX rats.\nC_LIO_LImicroRNA changes in untreated OVX rats are reverted by anti-osteoporotic therapy.\nC_LIO_LImiR-203a is up-regulated during bone loss and down-regulated following therapy.\nC_LIO_LIBone tissue and serum levels of miR-203a are highly correlated.\nC_LI

molecular biology↗